Verschenken Sie 15% Rabatt und erhalten Sie 10% zurück auf jede Bestellung, die diese Person aufgibt.
Verbindung in Forschungsqualität. Nur zur Verwendung im Labor. Nicht für die Anwendung am Menschen oder am Tier, zur Einnahme oder zur Injektion bestimmt. Es werden keine medizinischen Aussagen getroffen oder impliziert.
Forschungsverbindungen — ≥98% Chargenspezifikation des Lieferanten, ausgewählte Chargen unabhängig getestet
Lyophilisierte Peptide in versiegelten Fläschchen. Wird gemäß einer Chargenspezifikation des Lieferanten von ≥98% geliefert; ausgewählte Chargen werden unabhängig getestet.
Tabletten und Kapseln für die Forschung zur oralen Verabreichung.
Bakteriostatisches Wasser, Spritzen und Zubehör zur Rekonstitution.

Tirzepatide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only.

Research-grade Liraglutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
10mgResearch-grade Retatrutide + Cagrilintide Blend. ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.

Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist peptide studied for metabolic and insulinotropic signalling pathways in vitro research. Features a C-20 fatty diacid moiety enabling extended pharmacokinetic profile. Shipped to a ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Key research areas: Dual incretin receptor signaling and glucose-dependent insulin secretion Insulin-sensitivity and metabolic-homeostasis pathways studied in research models Body-weight and energy-balance signalling studied in research models For research purposes only. Not for human consumption.

Semaglutide is a long-acting GLP-1 receptor agonist peptide analogue (CAS 910463-68-2), supplied by CertaPeptides as lyophilized powder (injectable format) and oral tablets (3mg, 7mg) for laboratory research use only (≥98% supplier batch specification; selected lots independently tested, 99.3% avg across published reports). It is widely used as a long-acting reference GLP-1R agonist in incretin receptor-pharmacology and preclinical metabolic-model research. For laboratory research use only. Not for human consumption.

Retatrutide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only.

Research-grade Mazdutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.